Corning Life Sciences Cell & Gene Tech Expo April 2026: Cell Therapy

From Bench to Bioproduction: Scalable MSC Expansion Using Corning Solutions

Efficiently scaling mesenchymal stem cell (MSC) production requires a careful balance between high productivity and the preservation of cellular quality. Standard protocols often rely on complex coating steps and frequent media exchanges, which introduce unnecessary contamination risks and increase labor costs. Recent experimental data highlights a more streamlined approach using Corning MSCulture Max media. This specialized formulation eliminates the need for surface coatings and media exchanges during standard five-day cultures, significantly reducing process interventions.

When coupled with Corning HYPERStack vessels, which utilize gas-permeable film technology to provide massive surface area in a compact footprint, researchers can achieve yields of over one billion cells per vessel. This session details practical workflows for bone marrow and umbilical cord-derived MSCs, demonstrating how integrated technology can ensure robust, reproducible growth and phenotypic consistency. Learn how to optimize your scale-up strategy by viewing the full presentation.

About Corning Life Sciences

Corning Life Sciences is a global, leading manufacturer of lab tools for growing cells, bioprocess manufacturing, liquid handling, benchtop equipment, among other solutions for life sciences. Corning strives to improve efficiencies and develop innovations that enable scientists and therapy manufacturers to harness the power of cells to create breakthrough discoveries in areas like gene, stem cell, immune therapies, as well as vaccine development. Visit www.corning.com to learn more about Corning solutions for bioproduction.